LRCX vs TECX · P/E 71, rev $23.23B vs $567.2M cap
Lam Research Corp (LRCX) versus Tectonic Therapeutic, Inc. (TECX) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ.
Tectonic Therapeutic, Inc. (TECX) is a biotechnology company listed on NASDAQ.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. Revenue was up 26.0% from 2025-06-29 to 2026-06-28. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
TECX does not have a complete income-statement cache yet.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. TECX currently screens at market cap $567.2M.
Not investment advice. Open the LRCX and TECX stock pages for the full models.
Not investment advice.